A detailed history of Wellspring Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wellspring Financial Advisors, LLC holds 777 shares of LLY stock, worth $579,797. This represents 0.08% of its overall portfolio holdings.

Number of Shares
777
Previous 636 22.17%
Holding current value
$579,797
Previous $576 Million 19.54%
% of portfolio
0.08%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $108,871 - $135,362
141 Added 22.17%
777 $689 Million
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $176,868 - $221,805
244 Added 62.24%
636 $576 Million
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $232,142 - $310,573
392 New
392 $305 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $185,534 - $216,184
577 New
577 $211,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wellspring Financial Advisors, LLC Portfolio

Follow Wellspring Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellspring Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellspring Financial Advisors, LLC with notifications on news.